ES2938626T3 - Modulación del metabolismo de los lípidos para la producción de proteínas - Google Patents
Modulación del metabolismo de los lípidos para la producción de proteínas Download PDFInfo
- Publication number
- ES2938626T3 ES2938626T3 ES17724770T ES17724770T ES2938626T3 ES 2938626 T3 ES2938626 T3 ES 2938626T3 ES 17724770 T ES17724770 T ES 17724770T ES 17724770 T ES17724770 T ES 17724770T ES 2938626 T3 ES2938626 T3 ES 2938626T3
- Authority
- ES
- Spain
- Prior art keywords
- cell
- lmm
- product
- nucleic acid
- lipid metabolism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0097—Oxidoreductases (1.) acting on reduced flavodoxin as donor (1.19)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
- C12Y114/19001—Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662330973P | 2016-05-03 | 2016-05-03 | |
| PCT/EP2017/060484 WO2017191165A1 (en) | 2016-05-03 | 2017-05-03 | Modulation of lipid metabolism for protein production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2938626T3 true ES2938626T3 (es) | 2023-04-13 |
Family
ID=58745198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17724770T Active ES2938626T3 (es) | 2016-05-03 | 2017-05-03 | Modulación del metabolismo de los lípidos para la producción de proteínas |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10655111B2 (enExample) |
| EP (1) | EP3452608B1 (enExample) |
| JP (1) | JP6959942B2 (enExample) |
| KR (1) | KR102536221B1 (enExample) |
| CN (1) | CN109415748A (enExample) |
| AU (1) | AU2017259010B2 (enExample) |
| CA (1) | CA3023038C (enExample) |
| EA (1) | EA201892503A1 (enExample) |
| ES (1) | ES2938626T3 (enExample) |
| IL (2) | IL294241B2 (enExample) |
| MX (1) | MX2018013499A (enExample) |
| SG (1) | SG11201809626PA (enExample) |
| WO (1) | WO2017191165A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2938626T3 (es) | 2016-05-03 | 2023-04-13 | Lonza Ag | Modulación del metabolismo de los lípidos para la producción de proteínas |
| ES2871818T3 (es) * | 2018-02-02 | 2021-11-02 | Lonza Ag | Métodos de selección celular y modificación del metabolismo celular |
| US20210324366A1 (en) * | 2018-07-11 | 2021-10-21 | Cornell University | Supported plant plasma membrane lipid bilayer on-a-chip |
| CN120795059A (zh) | 2018-08-27 | 2025-10-17 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CN113348248B (zh) * | 2018-10-24 | 2024-12-31 | 思兰克斯有限公司 | 表达系统、重组细胞及其用途 |
| JP7574206B2 (ja) | 2019-03-20 | 2024-10-28 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ステロール調節エレメント結合転写因子１（ｓｒｅｂｆ１）阻害剤による上昇した脂質レベルの治療 |
| CN110317799B (zh) * | 2019-07-18 | 2026-04-03 | 江南大学 | 一种人源岩藻糖转移酶8的原核表达方法及其产品 |
| US20220403398A1 (en) | 2019-11-14 | 2022-12-22 | Lonza Ltd | Methods of cell selection |
| CN115029307A (zh) * | 2022-07-28 | 2022-09-09 | 吉林大学 | 一种延缓MSCs衰老的方法 |
| WO2026062080A1 (en) | 2024-09-17 | 2026-03-26 | Ares Trading S.A. | Cell having increased secretion capabilities and method of use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| JP3614866B2 (ja) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ，インコーポレイティド | 人工抗体ポリペプチド |
| EP1235842A4 (en) | 1999-10-15 | 2003-04-23 | Univ Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| AU2001275474A1 (en) | 2000-06-12 | 2001-12-24 | Akkadix Corporation | Materials and methods for the control of nematodes |
| AU2002321989A1 (en) | 2001-02-02 | 2002-12-03 | Bayer Corporation | Methods of modulating surfactant phospholipid production |
| JP2007500016A (ja) * | 2003-06-11 | 2007-01-11 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 培養においてタンパク質生成を増大させるための方法 |
| JP4783359B2 (ja) | 2004-04-16 | 2011-09-28 | ディーエスエム アイピー アセッツ ビー．ブイ． | 真菌細胞において遺伝子を発現させるための真菌プロモーター |
| EP1915394B1 (en) * | 2005-05-20 | 2021-01-27 | Lonza Biologics plc. | High-level expression of recombinant antibody in a mammalian host cell |
| US20080182249A1 (en) * | 2006-09-01 | 2008-07-31 | Fox Brian G | Expression systems for mammalian and mycobacterial desaturases |
| EP2209891A1 (en) | 2007-11-13 | 2010-07-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Improving the secretory capacity in host cells |
| US8809559B2 (en) * | 2008-11-18 | 2014-08-19 | Commonwelath Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
| HUE043103T2 (hu) * | 2013-02-01 | 2019-08-28 | Selexis Sa | Fokozott transzgén expresszió és processzálás |
| CN105849265B (zh) * | 2013-08-06 | 2021-03-26 | 英国龙沙生物医药股份有限公司 | 用于产生供生产重组蛋白的哺乳动物生产细胞的物品和方法 |
| ES2938626T3 (es) * | 2016-05-03 | 2023-04-13 | Lonza Ag | Modulación del metabolismo de los lípidos para la producción de proteínas |
-
2017
- 2017-05-03 ES ES17724770T patent/ES2938626T3/es active Active
- 2017-05-03 SG SG11201809626PA patent/SG11201809626PA/en unknown
- 2017-05-03 JP JP2018557851A patent/JP6959942B2/ja active Active
- 2017-05-03 US US15/585,570 patent/US10655111B2/en active Active
- 2017-05-03 IL IL294241A patent/IL294241B2/en unknown
- 2017-05-03 CN CN201780039286.6A patent/CN109415748A/zh active Pending
- 2017-05-03 CA CA3023038A patent/CA3023038C/en active Active
- 2017-05-03 WO PCT/EP2017/060484 patent/WO2017191165A1/en not_active Ceased
- 2017-05-03 KR KR1020187034453A patent/KR102536221B1/ko active Active
- 2017-05-03 AU AU2017259010A patent/AU2017259010B2/en active Active
- 2017-05-03 EP EP17724770.7A patent/EP3452608B1/en active Active
- 2017-05-03 EA EA201892503A patent/EA201892503A1/ru unknown
- 2017-05-03 MX MX2018013499A patent/MX2018013499A/es unknown
- 2017-05-03 IL IL262646A patent/IL262646B/en unknown
-
2020
- 2020-03-13 US US16/818,162 patent/US11434474B2/en active Active
-
2022
- 2022-07-27 US US17/815,465 patent/US20230047838A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3023038A1 (en) | 2017-11-09 |
| BR112018072434A2 (pt) | 2019-02-19 |
| EA201892503A1 (ru) | 2019-09-30 |
| US10655111B2 (en) | 2020-05-19 |
| US11434474B2 (en) | 2022-09-06 |
| EP3452608A1 (en) | 2019-03-13 |
| IL294241B2 (en) | 2023-10-01 |
| AU2017259010A1 (en) | 2018-11-22 |
| US20200231944A1 (en) | 2020-07-23 |
| AU2017259010B2 (en) | 2021-04-22 |
| WO2017191165A1 (en) | 2017-11-09 |
| KR20190003651A (ko) | 2019-01-09 |
| EP3452608B1 (en) | 2022-11-30 |
| CN109415748A (zh) | 2019-03-01 |
| KR102536221B1 (ko) | 2023-05-23 |
| CA3023038C (en) | 2023-03-14 |
| SG11201809626PA (en) | 2018-11-29 |
| JP2019514399A (ja) | 2019-06-06 |
| IL262646A (en) | 2018-12-31 |
| IL294241B1 (en) | 2023-06-01 |
| IL294241A (en) | 2022-08-01 |
| IL262646B (en) | 2022-08-01 |
| JP6959942B2 (ja) | 2021-11-05 |
| MX2018013499A (es) | 2019-09-11 |
| US20230047838A1 (en) | 2023-02-16 |
| US20170321194A1 (en) | 2017-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6959942B2 (ja) | タンパク質生成のための脂質代謝のモジュレーション | |
| ES2397274T3 (es) | Mejora de la producción de proteínas | |
| Messa et al. | Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits | |
| Jespersen et al. | The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4-like family | |
| Wiesinger et al. | Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction | |
| US20210137839A1 (en) | Compositions and methods for membrane protein delivery | |
| KR20210131991A (ko) | 구획-특이적 카고 전달을 위한 조성물 및 방법 | |
| ES2894323T3 (es) | Sistema y productos para una mejor cuantificación de la actividad ADCC | |
| Shah et al. | A dock-and-lock mechanism clusters ADAM10 at cell-cell junctions to promote α-toxin cytotoxicity | |
| US20240294585A1 (en) | Modular binding proteins for extracellular vesicles and uses thereof | |
| Hayashi et al. | Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion | |
| ES2972544T3 (es) | Métodos de selección celular y modificación del metabolismo celular | |
| Zheng et al. | Human YKT6 forms priming complex with STX17 and SNAP29 to facilitate autophagosome-lysosome fusion | |
| Nguyen et al. | Prokaryotic soluble overexpression and purification of human VEGF165 by fusion to a maltose binding protein tag | |
| AU2023277636A1 (en) | Compositions and methods for modulating genetic drivers | |
| Abdalla et al. | Control of preadipocyte proliferation, apoptosis and early adipogenesis by the forkhead transcription factor FoxO6 | |
| Ide et al. | Guanine nucleotide exchange factor DOCK11-binding peptide fused with a single chain antibody inhibits hepatitis B virus infection and replication | |
| Kotzamani et al. | Alpha helical structures in the leader sequence of human GLUD2 glutamate dehydrogenase responsible for mitochondrial import | |
| BR112018072434B1 (pt) | Método para produzir um polipeptídeo recombinante em uma célula | |
| CN104436189B (zh) | 一种肝肠胆固醇吸收的关键蛋白质Numb 及其用途 | |
| Shen et al. | Diverse functions of reactive cysteines facilitate unique biosynthetic processes of aggregate-prone interleukin-31 | |
| Hasib | Analysis of intracellular transport and functionality of human kidney anion exchanger 1 (kAE1) in yeast and mammalian cells | |
| Septisetyani et al. | Expression of Recombinant Human Erythropoietin with Glycosylation Modification in HEK293T cells | |
| Mozzanino | Engineering of the Secretory Pathway of CHO Cells for Recombinant Protein Production: Manipulation of SNARE Proteins | |
| Puji Septisetyani et al. | EXPRESSION OF RECOMBINANT HUMAN ERYTHROPOIETIN WITH GLYCOSYLATION MODIFICATION IN HEK293T CELLS. |